-
neuraminidase inhibitors drugs
zanamivir (Relenza), oseltamivir (Tamiflu), peramivir
-
neuraminidase inhibitors MOA
viruses have 2 surface proteins. hemagglutinins are responsible for the binding and uptake of the virus, while neuraminidases are responsible for release of new virus (via sialic acid cleavage). NIs block this cleavage, preventing release of new virus.
-
neuraminidase kinetics
Tamiflu oral, Relenza inhaled (so not for folks c respiratory disease)
-
neuraminidase indications
influenza
-
neuraminidase SE
GI. Tamiflu unusual dreams. Relenza possible bronchospasm
-
uncoating inhibitors drugs
amantadine (Symmetrel), rimantadine (Flumadine)
-
uncoating inhibitors MOA
flu A: thought to prevent influx of protons through viral M2 channels that causes the pH-dependent process of RNA-protein coat dissociation. parkinsons: amantadine may increase dopamine release and block ACh receptors, enhancing motor control.
-
uncoating inhibitors kinetics
amantadine more lipophilic, so more CNS SE than rimantadine (but better for Parkinsons)
-
nucleoside analogues MOA
viral enzymes convert nucleoside analogues to active nucleoside triphosphates, which are then incorporated and mess with viral DNA strands.
-
nucleoside analogues SE
nephrotoxicity. ganciclovir BBW hematologic toxicity, carcinogen, aspermatogenesis. cidofovir BBW nephrotoxicity, neutropenia, carcinogen.
-
most effective for reducing duration of cold sores
oral antivirals (nucleoside analogues)
-
what is given with probenecid?
cidofovir (high propensity for nephrotoxicity)
-
nucleoside analogues drugs
ALL THE CYCLOVIRS. acyclovir (Zorivax), valacyclovir (Valtrex), codofovir (Vistide)
-
nucleoside analogues indicated for herpes
acyclovir, famciclovir, penciclovir
-
nucleoside analogues indicated for CMV
ganciclovir
-
nucleoside analogues indicated for CMV retinitis
cidofovir IV
-
nucleoside analogues indicated for cold sores
penciclovir topical
-
azoles drugs
ALL THE AZOLES. fluconazole (Diflucan), 2G voriconazole (Vfend)
-
azoles MOA
block the synthesis of ergosterol, a fundamental constituent of the fungal cell membrane
-
azoles indications
superficial topical fungi (candida, dermatophytes), uncomplicated/health pt systemic fungi
-
azoles interactions
direct CYP450 inhibitors. inhibit warfarin metabolism (increase INR)
-
azoles SE
ketoconazole BBW hepatotoxicity. itraconazole BBW CHF (negative ionotropic effects).
-
echinocandins drugs
ALL THE FUNGINS. caspofungin (Cancidas), anindulafingin (Eraxis), micafungin (Mycamine).
-
echinocandins MOA
inhibits glucan synthase in fungal cell walls, an enzyme responsible for rigidity (causes weak cell walls that lyse).
-
echinocandins indications
severe invasive fungal infections (candida, aspergillus)
-
echinocandins SE
watch for anaphylaxis
-
griseofulvin MOA
inhibits fungal cell division by binding to proteins like tubulin.
-
griseofulvin kinetics
deposited into keratin precurson cells, increasing their resistance to infection.
-
griseofulvin indications
dermatophyte infections o skin/hair (trichophyton, microsporum, epidermophyton)
-
griseofulvin contraindications
porphyria, pregnancy, hepatic failures. caution if sensitive to penicillin.
-
griseofulvin interactions
CYP3A4 inducer.
-
griseofulvin SE
photosensitivity, rash
-
polyenes drugs
amphotericin B, Nystatin
-
polyenes MOA
bind sterols, such as ergosterol found in fungal cell membranes (puts pores in membrane, ions leak, cell dies). also b/c it binds sterols, also binds cholesterols causing its SEs.
-
polyenes kinetics
amphotericin B has long half life (15 days) b/c it is accumulated in tissues and released slowly. Nystatin too toxic for parenteral, but works good for topical/oral rinse due to low absorption.
-
polyenes indications
amphotericin B: serious invasive/systemic fungal infections. Nystatin: noninvasive candidal infections.
-
polyenes SE
nephrotoxicity, INFUSION REACTIONS, electrolyte abnormalities.
-
pyrimidines drugs
flucytosin (Ancoban)
-
pyrimidines MOA
taken up by cytosine permease, an enzyme present only in fungi. it is then metabolized (> 5-FU > 5-FDUMP) and goes on to inhibit thymidine synthetase (needed for DNA replication)
-
pyrimidines indications
severe fungal infections. use in combo with amphotericin B to prevent resistance.
-
pyrimidines SE
N/V (give capsules a few at a time over a 15 min period). BBW renal impairment. lots of other kick ass SE including TEN.
-
quinolines drugs
ALL THE QUINES. chloroquine (Aralen), hydroxychloroquine (Plaquenil).
-
quinolines MOA
largely unknown. chloroquine possibly concentrates in parasitic food vacules, causing toxic heme buildup. primaquine is the only drug that works on both the exoerythrocytic and erythrocytic phases of malarial infection (P vivax, P ovale).
-
quinolines indications
malaria (chloroquine first line). also RA, SLE, cutaneous skin disorders. quinine+clindamycin also for babesial infections.
-
quinolines contraindications
mefloquine seizures, some psych issues.
-
quinolines interactions
quinine+mefloquinine (QT prolongation, seizures). quinine+Aluminum antacids (messes c absorption/excretion).
-
quinolines SE
chloroquine visual disturbances (hydroxychloroquine is a less toxic alternative). quinine cinchonism (tinnitus, HA, nausea, dizziness, flushing, visual disturbances)
-
quinolines kinetics
slow elimination of mefloquine (second line) allows for single dose treatment (f/u c primaquine for liver bugs)
-
antihelmintics contraindications
praziquantal ocular infection, CNS lesions, seizure hx.
-
antihelmintics SE
albendazole alopecia, reversible leukopenia, elevated liver enzymes.
-
three types of worms (helminths)
nematodes (roundworms), trematodes (flukes), cestodes (tapeworms)
-
antihelmintics indicated for nematodes
mebendazole (-worms), diethylcarbamazine (filial), piperazine (ascaris), ivermectin/Stromectal (strongyloides, onchocerciasis - also scabies)
-
antihelmintics indicated for trematodes
praziquantal/Biltricide
-
antihelmintics indicated for cestodes
praziquantal/Biltricide, albendazole/Albenza (neurocysticercosis, Hydatid disease)
-
antihelmintic albendazole MOA
disrupts microtubule formation, impairs glucose uptake. also larvicidal, ovicidal.
-
antihelmintic diethylcarbamazine MOA
immobilize microfilariae and render them more susceptible to host defenses
-
antihelmintic praziquantal MOA
paralyzes (increases Ca++ permiability)
-
antihelmintic piperazine MOA
paralyzes (promotes GABA)
-
antihelmintic ivermectin MOA
paralyzes (intensifies GABA via Cl- channel activation)
-
antiprotazoals drugs
pentamidine (Pentam), melarsoprol, nifurtimox, iodoquinol (Yodoxin)
-
antiprotazoal MOA
melarsoprol disrupts protozoal enzymatic activity. nifurtimox inhibits trypanothione reductase.
-
antiprotazoal pentamidine (Pentam) indications
pneumocystis, African trypanosomiasis, leishmaniasis
-
antiprotazoal melarsoprol indications
trypanosomiasis
-
antiprotazoal nifurtimox indications
American trypanosomiasis (Chagas disease)
-
antiprotazoal SE
pentamidine hypotension/tachycardia, nephrotoxicity*, by IV hypoglycemia (so IM). melarsoprol reactive encephalopathy, polyneuropathy.
|
|